通心络对不稳定性心绞痛及超敏C―反应蛋白影响.docVIP

通心络对不稳定性心绞痛及超敏C―反应蛋白影响 　　【摘要】目的 探究应用通心络对不稳定性心绞痛及超敏C-反应蛋白的影响。方法 选取近两年在我院接受治疗的不稳定性心绞痛患者160例，将其分为对照组和试验组，每组80人，对照组常规药物治疗，试验组在对照组基础上口服通心络治疗，观察并比较两组患者经不同治疗方式后的疗效以及超敏C-反应蛋白的情况[1]。结果 试验组治疗后的总有效率（85.00%）明显高于对照组治疗后的总有效率（65.00%）；试验组治疗2周后的超敏C-反应蛋白（8.37±2.28）mg/L明显低于对照组治疗2周后的超敏C-反应蛋白（13.65±4.13）mg/L，两组差异有统计学有意义（P0.05）。结论 通心络治疗不稳定性心绞痛中，能有效缓解患者的心绞痛的症状，提高患者的睡眠质量。 　　【关键词】通心络；不稳定性心绞痛；超敏C-反应蛋白；影响 　　【中图文分类号】R541.4 【文献标识码】A 　　【Abstract】Objective To explore the application effect of Tongxinluo Capsule on unstable angina pectoris and high-sensitivity C- reactive protein. Method The selection of nearly two years of receiving treatment in our hospital 160 cases with unstable angina patients， they were divided into the control group and the experimental group， 80 in each group， the control group with routine therapy， the experimental group on the basis of the control group oral Tongxinluo treatment， observation and treatment effects were compared between the two groups after different treatment methods and after the ultra sensitive C- response protein[1]. Results The total efficiency of test group after treatment （85%） was significantly higher than the control group after treatment， the total efficiency（65%）； the experimental group for the treatment of high sensitivity C- reactive protein after 2 weeks （8.37±2.28） mg/L was significantly lower than that of control group in treatment of hypersensitive C- reactive protein after 2 weeks （13.65±4.13） mg/L， there was significant difference between two groups， with statistical significance （P0.05）. Conclusion Tongxinluo capsule for the treatment of unstable angina pectoris patients， can effectively alleviate the symptoms of angina， improve the sleep quality of patients. 　　【Key words】Tongxinluo； Unstable angina pectoris； High sensitivity C- reactive protein； Influence 　　心绞痛由于心肌严重缺血缺氧导致，其疼痛部位大多数位于胸骨后/或心前区，可放射到左上臂尺侧、下颌等处。患者通常在情绪波动范围大、身体劳累、感染风寒、天气不好时发作，往往出现很长时间，严重影响患者日常生活[2]。为了更好地分析通心络对不稳定性心绞痛的疗效及对超敏C-反应蛋白的影响，特在我院选取近两年的160例不稳定性心绞痛的患者，收集其资料进行整理分